Dendreon: Targeting Cancer, Transforming Lives
Home   |   Medical Affairs Web site   |   Site Map   |   Contact Us   
 Search
 

    Print Print page     Email Email page

SITE MAP

ABOUT US
  • Mission and Values
    • Corporate Responsibility
    • Corporate Compliance
  • Executive Leadership Team
    • John H. Johnson
    • Joe I. DePinto
    • Mark W. Frohlich, M.D.
    • Gregory T. Mayes
    • Christine Mikail
    • William J. Monteith
    • Lindsay M. Rocco
    • Gregory T. Schiffman
  • Board of Directors
    • Susan B. Bayh
    • Bogdan Dziurzynski, D.P.A.
    • Dennis M. Fenton
    • Pedro Granadillo
    • John H. Johnson
    • David C. Stump, M.D.
    • David L. Urdal, Ph.D.
    • Douglas G. Watson
  • Contact Us
  • Directions
PRODUCTS
  • PROVENGE
    • Manufacturing
    • Scientific Publications
PATIENT RESOURCES
  • Patient Access
  • Clinical Trials
  • Patient Information
RESEARCH AND DEVELOPMENT
  • Pipeline
  • Sipuleucel-T
  • ACI Product Candidates
  • TRPM8
  • Preclinical Programs
INVESTORS AND NEWSROOM
  • Governance
    • Executive Leadership Team
    • Board of Directors
  • Stock Quote
    • Historic Stock Lookup
    • Investment Calculator
  • Press Releases
  • Media Information
  • Webcasts and Presentations
  • SEC Filings
  • Analyst Coverage
  • Annual Reports
  • Information Requests
  • Email Alerts
  • Investor Tools
    • Brief Case
    • RSS Feeds
    • Email Alerts
    • IR Contacts
    • Download Library
CAREERS
  • Career Opportunities
  • Working at Dendreon
  • Your Benefits
Privacy Policy  |  Terms of Use  |  Medical Information  |  Cancer Immunotherapy Information
© 2011 Dendreon Corporation. All Rights Reserved.